GLP-1 drugs are revolutionizing the treatment of obesity and diabetes. Here's what to know about investing in GLP-1 stocks.

A recent study found that older adults with diabetes who use a GLP-1 drug have double the risk of developing wet age-related ...

Patients with chronic kidney disease who had hypertension and diabetes and received insulin therapy showed a 35% lower risk ...

Discontinuing the weight loss treatment before hitting the recommended maintenance dose contributes to low-value care despite ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Neither electronic nudge letters nor letters to general practice increase uptake of guideline-directed therapy among patients with CKD.

Panelists discuss how implementing cardiovascular-kidney-metabolic health requires a team-based approach using the analogy of football, where physicians coach multidisciplinary teams to help patients ...